Opto Circuit’s group company receives CE Certification for Revo 1100

20 Sep 2012 Evaluate

Unetixs Vascular Inc., a US based group company of Opto Circuits (India) and a leading manufacturer of peripheral vascular devices, has received CE (Conformite Europeenne) mark to market and sell its leading product Revo 1100 in Europe. The CE Certificate confirms that Revo 1100 met the necessary EU consumer safety, health and environmental requirements.

The Unetixs' Revo 1100 peripheral vascular diagnostic system and vascular profiler enables vascular technologists to perform noninvasive, simultaneous bilateral ankle (or toe) brachial index (ABI or TBI) tests, to detect Peripheral Arterial Disease (PAD). PAD is a disease in which plaque builds up in the arteries that carry blood to head, organs, and limbs.

The system also helps in conducting in-depth 'vessel specific' ABI studies for diagnosis or post-intervention follow-up, by obtain individual pressures & waveforms from the dorsalis pedis and posterior tibial arteries, or to detect reduced blood flow with Unetixs' virtually unbreakable TruDop continuous wave Doppler probes (available in 8 MHz and 5 MHz models).The system's dual-channel photoplethysmography (PPG) capability, incorporating easily applied PPG probes and digit clips, enables you to measure ABI and TBI pressures without holding a probe.

Opto Circuits (I) Share Price

1.78 0.00 (0.00%)
23-May-2022 18:01 View Price Chart
Peers
Company Name CMP
Poly Medicure 2581.85
Hemant Surgical Inds 136.50
Nureca Ltd. 273.50
Prevest Denpro 540.00
Centenial Surgical 125.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.